Asset Details
Do you wish to reserve the book?
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
Do you wish to request the book?
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
2012
Overview
The HER2/neu oncogene encodes a receptor-like tyrosine kinase whose overexpression in breast cancer predicts poor prognosis and resistance to conventional therapies. However, the mechanisms underlying aggressiveness of HER2 (human epidermal growth factor receptor 2)-overexpressing tumors remain incompletely understood. Because it assists epidermal growth factor (EGF) and neuregulin receptors, we overexpressed HER2 in MCF10A mammary cells and applied growth factors. HER2-overexpressing cells grown in extracellular matrix formed filled spheroids, which protruded outgrowths upon growth factor stimulation. Our transcriptome analyses imply a two-hit model for invasive growth: HER2-induced proliferation and evasion from anoikis generate filled structures, which are morphologically and transcriptionally analogous to preinvasive patients’ lesions. In the second hit, EGF escalates signaling and transcriptional responses leading to invasive growth. Consistent with clinical relevance, a gene expression signature based on the HER2/EGF-activated transcriptional program can predict poorer prognosis of a subgroup of HER2-overexpressing patients. In conclusion, the integration of a three-dimensional cellular model and clinical data attributes progression of HER2-overexpressing lesions to EGF-like growth factors acting in the context of the tumor's microenvironment.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Analysis
/ Anoikis
/ Breast Neoplasms - pathology
/ Carcinoma, Ductal, Breast - pathology
/ Cell Transformation, Neoplastic - pathology
/ Estrogen
/ Extracellular Matrix - physiology
/ Female
/ Humans
/ Intercellular Signaling Peptides and Proteins - physiology
/ Kinases
/ Lesions
/ Mammary Glands, Human - metabolism
/ Mammary Glands, Human - pathology
/ Medicine
/ Oncology
/ Patients
/ Precancerous Conditions - pathology
/ Proteins
/ Receptor, ErbB-2 - physiology
/ Spheroids, Cellular - physiology
/ Transcription, Genetic - physiology
/ Tumors
